Tianda Pharmaceuticals Ltd. (0455) Income Statement

0 Followers

Tianda Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2025), Tianda Pharmaceuticals Ltd.'s total revenue was HK$186.31M, a decrease of -38.61% from the same quarter last year. In Q4, Tianda Pharmaceuticals Ltd.'s net income was HK$-36.76M. See Tianda Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25	Dec 24	Dec 23	Dec 22	Mar 21
Total Revenue	HK$ 322.94M	HK$ 329.94M	HK$ 532.09M	HK$ 546.69M	HK$ 509.96M
Gross Profit	HK$ 133.31M	HK$ 152.02M	HK$ 255.53M	HK$ 251.52M	HK$ 241.22M
Operating Expenses	HK$ 187.40M	HK$ 206.17M	HK$ 284.56M	HK$ 321.66M	HK$ 283.25M
Depreciation and Amortization	HK$ 29.68M	HK$ 0.00	HK$ 36.41M	HK$ 50.25M	HK$ 22.15M
EBITDA	HK$ -24.41M	HK$ -49.49M	HK$ 15.66M	HK$ -19.89M	HK$ -5.14M
Operating Income	HK$ -54.09M	HK$ -54.15M	HK$ -29.02M	HK$ -70.14M	HK$ -38.97M
Other Income/Expenses	HK$ -15.24M	HK$ -191.00K	HK$ 3.33M	HK$ 6.29M	HK$ 10.96M
Pretax Income	HK$ -69.33M	HK$ -54.34M	HK$ -25.69M	HK$ -63.85M	HK$ -28.02M
Net Income	HK$ -70.00M	HK$ -61.37M	HK$ -24.16M	HK$ -54.64M	HK$ -21.67M
Per Share Metrics
Basic EPS	HK$ -0.03	HK$ -0.03	HK$ -0.01	HK$ -0.03	HK$ -0.01
Diluted EPS	HK$ -0.03	HK$ -0.03	HK$ -0.01	HK$ -0.03	HK$ -0.01
Weighted Average Shares Outstanding	2.15B	2.15B	2.15B	2.15B	2.15B
Weighted Average Shares Outstanding (Diluted)	2.15B	2.15B	2.15B	2.15B	2.15B

Currency in HKD

Tianda Pharmaceuticals Ltd. (0455) Income Statement

Tianda Pharmaceuticals Ltd. Income Statement

Tianda Pharmaceuticals Ltd. Earnings and Revenue History